Last reviewed · How we verify
CELZ-201 Administration
At a glance
| Generic name | CELZ-201 Administration |
|---|---|
| Sponsor | Creative Medical Technology Holdings Inc |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes (PHASE1, PHASE2)
- Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain (PHASE1, PHASE2)
- CELZ-201-DDT for the Treatment of Chronic Lower Back Pain
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |